We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
19 January 2016
VISCHER advises BiognoSYS AG, a leading company acting in the field of next-generation proteomics, in a significant series C funding from a corporate investment fund. The funds will be invested in establishing the business development and a new US service operation as well as in the development of new workflows and products for high-content protein analysis. The VISCHER Team was led by Dr. Matthias Staehelin (Partner) and Dania Salvisberg-Schneider (Senior Associate), both Corporate.
Categories: Corporate and commercial, Life Sciences, Pharma, Biotech, Startup Desk, Deals & Cases
Attorney at Law and Civil Law Notary (BS/BL)
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional...